FDA approves drug for autism irritability

Oct 13, 2006

The U.S. Food and Drug Administration approved Risperdal to treat irritability in autistic children and adolescents.

This is the first time the FDA approved a drug to treat behavior-related problems associated with autism in children, the FDA said in a news release. The drug can be used to treat aggression, deliberate self-injury and temper tantrums, all of which are classified under irritability.

Risperdal is an anti-psychotic drug used to treat adults with schizophrenia, the FDA said. In 2003, it was also approved as a short-term treatment for adults with acute manic episodes or extreme mood swings.

Risperdal is manufactured by Janssen Pharmaceutica N.V. in Beerse, Belgium.

Copyright 2006 by United Press International

Explore further: Prescription drug monitoring programs offer multiple benefits

Related Stories

VCs bet big on Silicon Valley biotech

May 28, 2015

Companies searching for cures for cancer and testing treatments for crippling genetic diseases are capturing the interest of venture capitalists - and their money - more than at any time in the last seven years.

Small RNA plays big role suppressing cancer

Apr 02, 2015

The micro RNA miR-22 has long been known for its ability to suppress cancer. However, questions remain about how it achieves this feat. For example, which molecules are regulating miR-22, and which are miR22 ...

Recommended for you

FDA clears drug for leading form of cystic fibrosis

Jul 02, 2015

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.